Growth, polymorphism, and spatially controlled surface immobilization of biotinylated variants of IAPP(21-27) fibrils by John, T. et al.
Growth, Polymorphism, and Spatially Controlled Surface
Immobilization of Biotinylated Variants of IAPP21−27 Fibrils
Torsten John, Juhaina Bandak, Nilushiya Sarveson, Claudia Hackl, Herre Jelger Risselada, Andrea Prager,
Christian Elsner, and Bernd Abel*
Cite This: Biomacromolecules 2020, 21, 783−792 Read Online
ACCESS Metrics & More Article Recommendations *sı Supporting Information
ABSTRACT: The islet amyloid polypeptide (IAPP) is a regulatory peptide that
can aggregate into fibrillar structures associated with type 2 diabetes. In this study,
the IAPP21−27 segment was modified with a biotin linker at the N-terminus (Btn-
GNNFGAIL) to immobilize peptide fibrils on streptavidin-coated surfaces. Key
residues for fibril formation of the N-terminal biotinylated IAPP21−27 segment
were identified by using an alanine scanning approach combined with molecular
dynamics simulations, thioflavin T fluorescence measurements, and scanning
electron microscopy. Significant contributions of phenylalanine (F23), leucine
(L27), and isoleucine (I26) for the fibrillation of the short peptide segment were
identified. The fibril morphologies of the peptide variants differed depending on
their primary sequence, ranging from flexible and semiflexible to stiff and crystal-like structures. These insights could advance the
design of new functional hybrid bionanomaterials and fibril-engineered surface coatings using short peptide segments. To validate
this concept, the biotinylated fibrils were immobilized on streptavidin-coated surfaces under spatial control.
■ INTRODUCTION
The assembly of soluble peptide or protein monomers into
fibrillar supramolecular structures, consisting of intermolecular
hydrogen-bonded β-sheets, is associated with serious degen-
erative diseases, such as Alzheimer’s disease, type 2 diabetes,
and other misfolding disorders.1,2 Despite their physiological
role, amyloid fibrils are promising tools for applications in
nanoelectronics, biosensing, and separation technologies.3−7
The preparation of amyloid fibrils in bulk quantities, from
readily available low-cost materials, could increase their
commercial potential in the near future.8 The advantage to
control the properties of these supramolecular structures by
tailoring the primary peptide sequence of the monomers is a
unique feature which enables a high flexibility in material
design.
The ability to control fibril morphology and fibrillation
kinetics enables to tailor their specific properties and
function.6,9 Amyloid fibril morphologies can differ in length,
diameter, and twist angle.10−12 It has been shown that the
length of fibrils influences its cytotoxicity and has an impact on
the membrane stability in a physiological environment.13,14
The fibril morphology is determined by its flexibility or
stiffness that results from the intermolecular forces and amino
acid side-chain properties.15,16 A uniform or homogeneous
morphology of fibrils is hardly achievable in vitro.17 Amyloid
fibrils exist in a variety of structural forms, and it has been
shown that the alteration of the solution conditions may favor
a particular morphology.8,18 For technical applications, the
fibrillation time and the option to control the fibrillation
process, e.g., to trigger the start of fibrillation, play a crucial
role. Light- or pH-stimulated fibrillation processes have been
investigated to address this topic.19,20
In this study, we investigated the influence of amino acid
substitutions in the primary peptide sequence of N-terminal-
modified NNFGAIL peptides (IAPP21−27) on the kinetics and
morphology of fibrillar structures. IAPP (islet amyloid
polypeptide, amylin) is associated with type 2 diabetes (Figure
1A.i).21,22 The identification of residues, which are less relevant
for fibril formation, could provide suitable targets for the
incorporation of functionalities into the peptide, for instance,
molecular switches, catalytic centers, labels, or functional
binding units. The IAPP21−27 peptide (NNFGAIL) is an
exception among other steric-zipper amyloid structures
reported by the Eisenberg group.23 Instead of interdigitated
side chains, the F23, G24, and A25 residues from neighboring
chains form a close main-chain/main-chain interface. The fibril
structure consists of a hydrophobic surface domain formed by
the side chains of I26 and L27 of one sheet and F23 of the
opposite sheet and a hydrophilic surface domain formed by
N21 and N22 of each sheet (Figure 1B).23 Alanine scanning of
each position in the peptide was performed to determine the
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influence of the corresponding amino acid on the fibrillation
process and the morphology of the fibrils.24
The peptide variants studied comprise an N-terminal
biotinylation of GNNFGAIL (Btn-GNNFGAIL, Figure
1A.iii). The primary function of the N-terminal biotinylation
is the generation of an accepted anchor for further
modifications by means of the high affinity of the biotin−
avidin/streptavidin system (Kd ≈ 10−14 mol/L) for surface
modification processes (Figure 1C).25,26 Glycine (G) was
introduced at the N-terminal position of NNFGAIL to enlarge
the spacer length between the aggregation-prone peptide
region and the biotin group for its surface immobilization and
to achieve possibly a highly aggregating peptide (Figure 1A.iii).
A naturally occurring polymorphic S20G mutation rendered
IAPP more aggregation-prone, and an Asian subpopulation
with this mutation has an early onset of type 2 diabetes (Figure
1A.ii).27,28 We performed thioflavin T (ThT) fluorescence and
scanning electron microscopy (SEM) measurements as well as
molecular dynamics (MD) simulations to study the role of
peptide modifications for the fibrillation kinetics and
morphologies. The hydrophobic peptide residues phenyl-
alanine (F23), isoleucine (I26), and leucine (L27) were
identified as highly relevant for peptide aggregation. Finally,
Btn-GNNFGAIL fibrils were successfully immobilized on
streptavidin-coated surfaces as a proof-of-concept to prepare
fibril-engineered surfaces.
■ EXPERIMENTAL SECTION
Materials. Chemicals were obtained from commercial sources as
follows: Fmoc-amino acids, preloaded Fmoc-amino acid-WANG
resins, biotin, thioflavin T (dye to detect amyloid fibrils), TIPS
(Sigma-Aldrich, St. Louis, MO); DMF (peptide synthesis grade),
piperidine (peptide synthesis grade), DIEA, diethyl ether (>99.5%)
(Carl-Roth, Karlsruhe, Germany); TFA (Merck, Darmstadt, Ger-
many); TBTU, HOBT (Fluka, Seelze, Germany); 2-propanol (HPLC
grade), DMSO (ultrapure) (VWR, Leuven, Netherlands); NNFGAIL
(Eurogentec, Seraing, Belgium); HFIP (99.9%, spectrophotometric
grade, Acros Organics, Geel, Belgium); Millipore-grade water (Milli-
Q Integral 5 laboratory purification system, Merck, Darmstadt,
Germany).
Peptide Synthesis and MALDI-TOF-MS. Modified peptides
were synthesized by microwave-assisted solid phase peptide synthesis
(SPPS) based on standard Fmoc chemistry (Fmoc deprotection: 20%
piperidine in DMF; coupling: TBTU/HOBT: 3 equiv, Fmoc amino
acid: 2.9 equiv, DIEA: 10 equiv in DMF) using an Initiator+ SP Wave
semiautomatic peptide synthesizer (Biotage, Uppsala, Sweden). The
peptide was cleaved from the resin in TFA/TIPS/water (95/2.5/2.5,
v/v/v) and precipitated after solvent evaporation in ice-cold diethyl
ether. The peptide was washed at least three times in diethyl ether by
resuspending and centrifugal precipitation. The identity of the
peptides was determined on an Autoflex III MALDI-TOF mass
spectrometer (Bruker, Bremen, Germany) in positive reflectron mode
using a HCCA matrix Prespotted AnchorChip target (PAC II target).
Observed mass-to-charge ratios are presented in Table S1. Standard
sample preparation was performed using the dry droplet method
according to the Bruker guide for MALDI sample preparation.
Peptides were dissolved in HFIP. For the calibration on the target, the
Bruker peptide calibration standard or poly(ethylene glycol) MW
1000 (PEG-1000) was used.
Thioflavin T (ThT) Fluorescence Assay. ThT fluorescence
assays were performed at a peptide concentration of 1 mg/mL. The
final concentration of ThT in the assays was 5 μM. Assays were
performed in polypropylene tubes with a total volume of 1 mL.
Peptide stock solutions of 100 mg/mL in DMSO were prepared. The
DMSO/peptide and aqueous ThT solution were rapidly mixed
(vortexed) and kept at 25 °C in a thermomixer (gentle shaking at
200 rpm). For fluorescence measurements (TECAN microplate
reader infinite 200, Man̈nedorf, Switzerland) after certain time
intervals, the vials were vortexed, treated with ultrasound for 5 min,
and vortexed; subsequently 200 μL aliquots were transferred into the
well of a microtiter plate and read out (λexc = 410 nm, λem = 485 nm, n
= 3). Averages and standard errors of the mean were calculated to
present the results.
Scanning Electron Microscopy (SEM) Measurements. Pep-
tide solutions were prepared at a concentration of 0.1 mg/mL
(50 mg/mL peptide stock in DMSO was used) and incubated for
several days. Droplets of the peptide solutions were deposited onto
silicon wafers (Plano, Agar Scientific, #G3390, Germany) after varying
times and air-dried. SEM images were recorded by using an Ultra 55
SEM (Carl Zeiss Microscopy, Oberkochen, Germany).
Spatially Controlled Fibril Surface Immobilization. Strepta-
vidin-coated glass slides (PolyAn 3D-Streptavidin glass slides, LOT:
180626, PolyAn, Berlin, Germany) were exposed to an atmospheric
Figure 1. Sequences and structural information about IAPP and IAPP21−27 and the relationship to functional properties. (A.i) Sequence of IAPP
with the IAPP21−27 segment of NNFGAIL as the assumed core structural domain for fibrillation in green. (A.ii) Sequence of an IAPP variation
found in an Asian subpopulation with accelerated type 2 diabetes (S20G shown in red). (A.iii) Studied peptide sequence for alanine scanning. (B)
Structural representation of a protofibril of the NNFGAIL (PDB: 3DGJ)23 segment from IAPP. Hydrophilic and hydrophobic domains within the
protofibril are shown. Molecular data were visualized by using the WebGL-based 3D viewer NGL from the RCSB PDB Web site.29 (C) Surface
modification strategy (schematic) for the spatial immobilization of biotinylated fibrils.
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oxygen plasma through a mask (Atomflow 500 system, Surfx
Technologies, U.S.; for details refer to the Supporting Information).
This method yielded areas in which the streptavidin was removed by
the plasma. The glass slide was incubated with 1 mL of fibrillation
solution as described in the section Thioflavin T (ThT) Fluorescence
Assay ([Btn-GNNFGAIL] = 1 mg/mL). The glass slide was covered
with a plastic cover plate to prevent evaporation of the solvent. After
2 days, the glass slide was extensively rinsed with ultrapure water,
dried, and then coated with a chromium layer to prevent charge
effects during SEM analysis.
Molecular Dynamics Simulations (MD). Structural information
for the heptapeptide NNFGAIL was obtained from the Protein Data
Bank (entry 3DGJ).23 Modifications of NNFGAIL, namely
NNGGAGL, GNNFGAIL, and Btn-GNNFGAIL, were prepared by
using the Maestro suite 2015 (Schrödinger, New York, NY). The
biotin structure was obtained from the Automated Topology Builder
(ATB) and Repository (Molid 2212).30−32 The peptides were studied
with charged termini at pH 7. Topology information for the peptides
without biotin (NNFGAIL, NNGGAGL, and GNNFGAIL) was
included in the applied force field. The biotin-modified peptide (Btn-
GNNFGAIL) was parametrized by using the ATB according to the
Gromos philosophy. The topology information for the amino acids
was taken from the force field and for biotin from the ATB (Molid
2212). The amide bond between biotin and peptide was obtained
from the ATB (Molid 26960) by generating parameters for a
biotinylated lysine.30−32
Five-stranded protofibrils with two β-sheets (5 × 2) were built for
all peptides by using the crystal structure information (P212121)
known for NNFGAIL as the reference starting structure.23 For each
system, the protofibril was placed in an octahedral periodic box with
minimal distances of at least 1.2 nm between the solute and the box
edges. The simulation boxes with the protofibrils were solvated in
explicit water by using the simple point charge (SPC) model.33
Sodium chloride was added as physiological salt (0.15 mol/L).
MD simulations were performed using GROMACS 4.5.734−37 and
the GROMOS 54A7 united-atom force field38 at 300 K. All peptide
bonds were constrained to their equilibrium values by using the
LINCS algorithm.39,40 Water was constrained by using the SETTLE
algorithm.41 Both Coulomb and van der Waals interactions were
described with a cutoff distance of 1.4 nm (single cutoff). Interactions
were updated every fifth step with the charge-group-based pair list.
The reaction-field method was applied to correct for long-range
electrostatic interactions (dielectric constant of the reaction field,
ε = 78).42 Periodic boundary conditions were applied in all three
dimensions. A 2 fs time step was used for the integration of the
equations of motion. Simulation settings were adapted from the work
of Periole et al.43 The protofibril systems were initially energy
minimized in two steps in a steepest-descent algorithmfirst with the
peptide atom positions restrained (100 ps, k = 1000 kJ mol−1 nm−2)
and second without any positional restraints (100 ps). The
simulations were run in an isothermal−isobaric ensemble (NPT).
Peptide and water/ions were independently coupled to a Berendsen
temperature thermostat with a reference temperature of 300 K and a
relaxation time of 0.1 ps.44 The pressure was maintained at 1 bar by
coupling the system to a Berendsen isotropic pressure barostat with a
relaxation time of 1 ps and compressibility of 4.6 × 10−5 bar.44 After
equilibration of the systems with position restrained peptide backbone
(k = 100 kJ mol−1 nm−2), the simulations were run in three unbiased
repetitions, each with random starting velocities fitted to a Boltzmann
distribution. The center-of-mass translation was independently
removed for protein and water/ions. The MD simulations were run
for 100 ns to study the protofibril stability.
Simulation trajectories were visualized by using VMD45 and
analyzed using GROMACS tools. Either representative or averaged
data of the three repetitions were shown and plotted by using
OriginPro 8G (OriginLab, Northampton, MA). Clustering analysis of
the last 10 ns of simulation time of all three repetitions each (3 ×
10 ns) was performed for all variants, and the central structure of the
largest cluster was visualized in VMD as the most dominant structure
(linkage method, RMSD cutoff 0.2 nm). Root-mean-square deviations
(RMSD) of the peptide backbone were calculated in comparison to
the starting structure. RMSD data for the triplicate simulations were
averaged. Root-mean-square fluctuations (RMSF) of the peptide and
biotin residues were analyzed and averaged for all three repetitions.
The φ/ψ dihedral combinations of the peptides were calculated and
represented in Ramachandran plots for the most dominant structure
present during the last 10 ns simulation time. The secondary structure
content of the oligomeric protofibril systems (for main chain atoms)
was analyzed for the last 10 ns simulation time by using the DSSP tool
(Define Secondary Structure of Proteins) that was developed by
Kabsch and Sander.46,47 Hydrophobic and hydrophilic solvent
accessible surface areas (SASA) and solvation free energies per area
were calculated for all systems for the last 10 ns of simulation
time.48,49 Averages and standard errors were calculated for all
parameters derived from the MD simulations.
Theoretical Prediction of the Solubility and Aggregation
Propensities of GNNFGAIL Variants. The aggregation propensities
of the GNNFGAIL variants (without Btn) were theoretically
predicted by using CamSol50,51 (www-vendruscolo.ch.cam.ac.uk/
camsolmethod.html) and AGGRESCAN52 (bioinf.uab.es/aggrescan/
). The biotin modification (Btn) is not parametrized in these
algorithms. CamSol is a computational method that is based on the
physicochemical properties of amino acids that are responsible for
peptide solubility in water (e.g., hydrophobicity and electrostatic
interactions). Intrinsic residue solubility profiles were determined
based on the individual amino acids with respect to a window of
neighboring residues. The CamSol intrinsic solubility score was
calculated from residue solubility profiles. The AGGRESCAN
algorithm is based on an aggregation-propensity scale for all natural
amino acids. Aggregation profiles (a4v) are determined as window
average of the amino acid aggregation-propensity values (a3v) of
individual amino acids to account for the neighboring residues as well.
■ RESULTS AND DISCUSSION
Fibril Stability of Biotinylated GNNFGAIL. A peptide
system with high aggregation propensity and a biotin anchor
for conjugation of the fibrils to other structural elements based
on the biotin−streptavidin system was established. Molecular
dynamics (MD) simulations were performed to obtain
information about the stability and the propensity to form
structural fibril motifs in substituted peptides. The study
involved the wild-type (wt) peptide NNFGAIL, GNNFGAIL
(considering the N-terminal S20G substitution), and Btn-
GNNFGAIL. In addition, the NNGGAGL peptide was studied
to validate our method, as fibrils of this variant were previously
shown to be unstable in MD simulations.53 The MD starting
structures consisted of five-stranded protofibrils with two
β-sheets (5 × 2). To monitor the stability or disassembly of the
modeled peptide oligomer structures, the systems were
simulated for 100 ns, starting with the known fibril structure
of NNFGAIL for all peptide variants. The most dominant
structures of the NNFGAIL, NNGGAGL, GNNFGAIL, and
Btn-GNNFGAIL peptides during the last 10 ns of simulation
time are shown in Figure 2a. The protofibril structure of
NNGGAGL was significantly disturbed and not stable, as
previously reported.53 NNFGAIL, GNNFGAIL, and Btn-
GNNFGAIL had a higher fibril stability. The root-mean-
square deviations (RMSD) of the peptide backbones and the
root-mean-square fluctuations (RMSF) of the peptide residues
were calculated to quantify the stability or disassembly of
peptide oligomer structures (Figure 2b).53−55 The
NNGGAGL protofibril had the lowest stability, confirming
the importance of the hydrophobic side chains phenylalanine
(F23) and isoleucine (I26) for peptide fibril formation.53 The
extension of the wild-type sequence (GNNFGAIL and Btn-
GNNFGAIL) enhanced the peptide fibril stability. In fact, Btn-
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GNNFGAIL had final RMSD and RMSF deviations similar to
NNFGAIL. However, the deviations for Btn-GNNFGAIL at
the start of the simulations resulted from an optimization of
the protofibril structure since the starting configuration of Btn-
GNNFGAIL was assumed as for NNFGAIL. In contrast, the
deviations for NNFGAIL after around 50 ns were caused by a
partial disintegration of the fibril structure. The GNNFGAIL
protofibril was similarly stable as for Btn-GNNFGAIL; it did
not need to optimize its structure as the addition of glycine
(G) did not lead to larger structural changes.
Ramachandran plots of the most dominant peptide
structures during the last 10 ns simulation time show a loss
of the characteristic β-sheet structure of NNGGAGL whereas
both GNNFGAIL and Btn-GNNFGAIL present an enhance-
ment compared to NNFGAIL. The Ramachandran plots and
the β-sheet and β-bridge secondary structure content of the
last 10 ns of simulation time are shown in Figure 3. The
highest β-sheet content was observed for Btn-GNNFGAIL.
The MD simulations thus revealed that the N-terminal
modification of NNFGAIL with Btn-G had a positive impact
on the stability of the peptide fibrils. Btn-GNNFGAIL also had
the highest hydrophobic surface accessible surface area (SASA)
and solvation free energy per area, indicating its high
aggregation propensity (Supporting Information Figure S1).
Experimental studies on the fibrillation kinetics of
NNFGAIL, GNNFGAIL, and Btn-GNNFGAIL based on
thioflavin T (ThT) fluorescence confirmed the simulation
results (Figure 4). ThT fluorescence assays are based on
changes in the fluorescence properties of the ThT dye upon its
binding to β-sheet-rich fibrils.56,57 Btn-GNNFGAIL aggregated
much faster than NNFGAIL and GNNFGAIL. GNNFGAIL at
first seemed stable in the simulations; however, it had a lower
β-sheet content, hydrophobic domain, and solvation free
energy per area than the wild-type NNFGAIL (see Figure 3
and Figure S1). Thus, GNNFGAIL fibrils might be stable once
formed, but a similar or lower aggregation propensity as for
NNFGAIL is expected. Although its aggregation kinetics were
slower, typical amyloid fibrils were also found for NNFGAIL
when studied by electron microscopy (SEM; see Figure S2).
This is likely due to the SEM sample preparation, as the
peptide solution was air-dried on the substrate which increased
the peptide concentration and thus accelerated fibril growth.
Fibril Formation Kinetics of Alanine Scanning
Variants of Btn-GNNFGAIL. To understand the role of
single amino acids within Btn-GNNFGAIL for fibril growth
and morphology, alanine scanning of the Btn-GNNFGAIL
peptide was carried out. Compared to glycine and proline
substitutions (β-sheet breaker), it is assumed that alanine
scanning has a reduced impact on the peptide backbone, which
is important for NNFGAIL-derived peptides since their
fibrillation is promoted by backbone−backbone interactions
of the individual strands (Figure 1B).23 The kinetics of amyloid
fibril formation was followed using ThT binding assays (Figure
4).56,57 The data show the fluorescence intensity after several
time intervals under identical ambient conditions for each
peptide (temperature and shaking intensity). Both the
fluorescence intensities and the lag times for fibril formation
vary between the peptide variants. This indicates that the side-
chain functionalities in the IAPP21−27 peptide have a distinct
influence on the nucleation and elongation phase of peptide
aggregation. Considering the value after 1 day of incubation
(green bars), the peptide variants Btn-GNN(F23A)GAIL, Btn-
GNNFGA(I26A)L, Btn-GNNFGAI(L27A), and Btn-GN-
(N22A)FGAIL had a reduced fluorescence intensity compared
to the other peptides. This suggests that the residues F23, I26,
L27, and N22 are important for the formation of β-sheet-rich
nuclei that seed fibril formation. Once β-sheet-rich structures
were formed for Btn-GN(N22A)FGAIL and Btn-GNN-
(F23A)GAIL after a lag time of several days, those peptide
variants also aggregated. While Btn-GN(N22A)FGAIL rapidly
Figure 2. (a) The most dominant structures of the last 10 ns of simulation time (of all three repetitions each) are shown with the peptides in
cartoon representation and Btn-G in licorice representation. Clustering analysis was performed, and the central structure of the largest cluster was
determined. (b) Root-mean-square deviations (RMSD) for the peptide backbone and root-mean-square fluctuations (RMSF) of all peptide
residues and biotin were calculated over the simulation time of 100 ns. Standard errors of the mean are shown.
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formed mature fibrils once the nuclei were present, Btn-
GNN(F23A)GAIL elongation was retarded, too. After one
month of incubation, significant fluorescence signals were
found in all samples, except for Btn-GNNFGA(I26A)L. The
longest lag times of fibrillation were observed for the variants
Btn-GNN(F23A)GAIL and Btn-GNNFGAI(L27A).
Morphologies of Alanine Scanning Variants of Btn-
GNNFGAIL. The peptide fibril morphologies after 1 and 17
days were studied by SEM (Figure 5 and Figure S3). After 1
day, large amounts of fibrils were formed for almost all alanine
scanning variants, when dried on silicon wafers, with the
exception of Btn-GN(N22A)FGAIL, Btn-GNN(F23A)GAIL,
and Btn-GNNFGAI(L27A). In these cases, mostly amorphous
peptide aggregates cover the surface of the silicon wafers,
which have a tendency to arrange in a more or less nonordered
phase. Btn-(G20A)NNFGAIL and Btn-G(N21A)NFGAIL
formed thinner fibril structures, while Btn-GNNF(G24A)AIL,
Btn-GNNFGAIL, and Btn-GNNFGA(I26A)L formed thicker
ones. The morphologies of the supramolecular structures differ
from mature NNFGAIL fibrils. NNFGAIL forms extremely
dense fibril associates with a crystal-like superlattice and a high
degree of stiffness (Figure 5 and Figure S2). In contrast, single
fibrils of Btn-(G20A)NNFGAIL are arranged in flexible ring-
shaped structures, which can be compressed to tight gels
(Figure 5 and Figure S3). The stiffness appears dramatically
reduced. The same feature was ultimately found for the Btn-
GNNFGAIL, indicating that the N-terminal modification has a
high impact on the morphology of the fibrils, which is likely
based on their intrinsic flexibility. After 17 days, the
morphology slightly changed for the peptide Btn-G(N21A)-
NFGAIL which formed needle-like fibrils, which was not
obvious after 1 day. A much higher amount of fibrils was
observed for Btn-GNNFGA(I26A)L after 17 days with a
comparable morphology to Btn-(G20A)NNFGAIL, Btn-
GNNFGAIL, and Btn-GNNF(G24A)AIL (Figure S3). The
double variant Btn-GNN(F23A)GA(I26A)L formed no fibrils,
even after 17 days. For Btn-GNNFGA(I26A)L, no fibrils were
found in the ThT fluorescence assay after 1 day, while SEM
revealed some fibrillar structures. This is likely caused by
surface concentration effects during sample preparation for
SEM. While the peptide containing droplets air-dried on the
silicon supports, the peptide concentration increased, which
increased the propensity for peptide aggregation.
Our results indicate that the substitution of F23A has a large
negative impact on the formation of mature fibrils. Thus, F23
is a key residue for the aggregation of Btn-GNNFGAIL. This
result is consistent with previously reported MD simulations,53
where glycine scanning variants of the non-biotinylated wild-
type NNFGAIL were studied to understand the effect of
single-point substitutions on the amyloidogenic propensity in
terms of the sheet-to-sheet and strand-to-strand interactions.
In agreement with our experimental results, the variants
NN(F23G)GAIL and NNFGA(I26G)L had a lower fibril
stability followed by (N21G)NFGAIL and N(N22G)FGAIL.
Our findings also agree with previous observations when IAPP
(segment) mutations were investigated. For instance, the
variants N(F23Y)GAILSS, SN(N22P)FGAILSS, SNNFGA-
(I26P)LSS, and SNNFGAI(L27P) aggregated to a lower
extent.58,59 No or a reduced amyloid fibril formation was
observed under experimental conditions when phenylalanine
Figure 3. (a) Ramachandran plots for the most dominant structures
(as shown in Figure 2a) and (b) overview of β-sheet and β-bridge
secondary structure content (sum = β-sheet + β-bridge) during the
last 10 ns of simulation time according to the DSSP algorithm.
Negative phi and positive psi angles are characteristic for β-sheet
structures. Larger parts of the peptide structures were identified as
random coil. Standard errors of the mean are shown.
Figure 4. Comparison of the fibrillation kinetics of the wild-type
NNFGAIL, GNNFGAIL, and Btn-GNNFGAIL and its alanine
scanning variants using ThT fluorescence spectroscopy ([peptide]
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was replaced with alanine in full-length IAPP and selected
peptide segments.60 A summary on the influence of amino acid
substitutions in IAPP and derived peptides from previous
studies is provided in Table S2, emphasizing the role of each
residue.
Theoretical Predictions. Theoretical predictions based on
the contribution of each amino acid in GNNFGAIL to the
overall solubility and propensity to form fibrillar aggregates
revealed that the F23A variant had the largest impact, followed
by I26A and L27A (Figure 6).50−52 These calculations are in
Figure 5. SEM images of fibrils of the alanine scanning peptides of Btn-GNNFGAIL after 24 h ([peptide] in the fibrillation assay = 0.1 mg/mL).
Figure 6. Differences in the aggregation kinetics of the Btn-GNNFGAIL variants in the ThT fluorescence assay were compared to theoretical
solubility and aggregation prediction models of GNNFGAIL. (a) CamSol intrinsic residue solubilities of the GNNFGAIL variants.50,51 Low values
indicate a low solubility and possibly high aggregation propensity. Regions below −1 have a very low solubility. (b) AGGRESCAN aggregation
profiles of the GNNFGAIL variants.52 Higher values (above −0.02) indicate regions of high aggregation propensity. (c) Comparison of
experimental ThT fluorescence intensities of Btn-GNNFGAIL variants after 1 and 14 days with the CamSol intrinsic solubility scores of the
GNNFGAIL variants.50,51 Overall, low CamSol intrinsic solubility scores related to a large aggregation in the kinetic assay. An exception was
GN(N22A)FGAIL after 1 day, likely due to a kinetic effect (longer lag time). Gray dashed lines are used to guide the reader’s eye (based on linear
fits of data); however, no mathematical correlation is intended.
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agreement with the experimental results obtained in the ThT
kinetic assay and SEM measurements for Btn-GNNFGAIL,
confirming the high relevance of the phenylalanine, isoleucine
and leucine residues for peptide fibril formation, especially its
early nucleation phase. It needs to be noted that the
predictions were made for GNNFGAIL variants since the
biotin modification (Btn) is not parametrized in these
algorithms. Thus, it was assumed that biotin has the same
effect on solubility in each peptide variant. This assumption
might have led to deviations in the trend of the predictions. A
lower solubility and higher aggregation propensity were found
for the G20A, N21A, N22A, and G24A variants compared to
the unmodified GNNFGAIL peptide, in agreement with the
ThT assay (Figure 4). One outlier between the predicted
solubility for GNNFGAIL variants and the experimentally
observed amyloid formation for Btn-GNNFGAIL after 1 day is
the N22A variant. Although this variant is poorly soluble, it did
not form many fibrils. This could be likely due to the
biotinylation or a kinetic effect, increasing the lag time for the
formation of a critical nucleus, until large amounts of fibrils
were formed after 3 days (Figures 4 and 6).
The substitution of phenylalanine in the variant Btn-
GNN(F23A)GAIL had a negative impact on the formation
of fibrils. Considering the arrangement of amino acid side
chains from the X-ray structure, strand-to-strand hydrophobic
interactions of phenylalanine−isoleucine are the main
interaction modes (see Figure 1B).23 The substitution of
phenylalanine with the smaller and less hydrophobic alanine
(or glycine) reduced these attractive interactions, independent
of the incorporation of biotin into the peptide. The importance
of hydrophobic residues and π-stacking for amyloid fibril
formation has previously been reported.60−62 Contrarily,
alanine substitutions at positions N21 and to a lesser extent
G24, considering steric restrictions from the X-ray structure,
had only a minor impact on the fibrillation process, and
therefore these sites are suitable candidates for further
substitution and modification processes. However, the impact
of modifications on peptide fibrillation will also depend on the
size and structure of the incorporated groups. To study
biologically relevant peptides or proteins, label-free approaches
should be favored to reproduce the original fibril kinetics and
morphologies.
Immobilization to Streptavidin-Coated Surfaces.
Fibril-modified surfaces are of interest for different purposes,
for instance, their usage as a new class of morphologically and
chemically engineered biomaterials, which may be involved in
fibril−cell or fibril−nanoparticle interactions.63−68 Because the
amount of biological sample materials is limited, microfluidic
approaches are readily advantageous over conventional
laboratory techniques.69 The spatially controlled immobiliza-
tion of fibrils to surfaces is the first step toward their
integration into multifunctional microfluidic systems. A
streptavidin-coated glass slide was used as a model to
demonstrate the spatial immobilization of biotinylated fibrils
to surfaces as a first proof-of-concept, however, even other
binding concepts may be suitable. To achieve the goal, the
streptavidin-coated slide was exposed to an atmospheric
oxygen plasma through a mask allowing for streptavidin
inactivation and degradation at the exposed areas. Different
surface modification techniques, such as laser structuring,
could also be applied at this stage.70 After treatment, exposed
and unexposed areas were incubated with a peptide solution of
Btn-GNNFGAIL under fibrillation conditions (Figure 1D).
The spatial resolution for fibril immobilization on the surface
by using this approach is limited by the resolution of the
streptavidin structure on the glass slide obtained during the
oxygen plasma treatment.
SEM revealed a higher degree of immobilized fibrils in the
streptavidin-coated areas, whereas plasma-cleaned areas
showed a much lower degree of bound fibrils (Figure 7 and
Figure S4). Image analysis (Matlab R2018b, Gwyddion 2.5271)
revealed a fibril surface coverage of at least 24% on the
streptavidin-coated (untreated) area and 5% fibril coverage on
the plasma-treated side (see Figure S5 for masked images).
Instead of a homogeneous surface coverage, the fibrils formed
islets of a few tens of micrometers (Figure 7c). Smaller and
thinner fibrils can be seen in the areas in between these larger
fibril aggregates. While the image analysis only considered the
larger fibril aggregates, the results demonstrate that amyloid
fibrils were spatially controlled immobilized by using the
biotin−streptavidin interaction.
The herein-presented approach is highly compatible with
our recently developed method of inverse microfluidic printing
(cryoprinting).72 Cryoprinting enables the fabrication of
microfluidic systems on a time scale of a few minutes by
aqueous printing and freezing of microstructures on glass slides
by using the drop-on-demand technology, which are
subsequently encapsulated in a photocured polymer within
milliseconds. Once the ice template melts, a microfluidic
polymer channel is obtained on the glass slide. Fibrillar
nanostructures and their gels could thus be integrated into
such microfluidic systems under spatial control in the near
future. The immobilized fibrils on the glass slide could serve as
affinity materials73,74 or templates for electrode materials6,75
within the microchannel that was formed.
■ CONCLUSIONS
To obtain insight into the contribution of single amino acids
on the fibrillation of Btn-GNNFGAIL peptide (Btn-G-
Figure 7. SEM images of spatially immobilized fibrils of Btn-
GNNFGAIL on a streptavidin-coated glass slide. (a) While the left
side of the streptavidin-coated glass slide was untreated, the right side
was cleaned under an oxygen plasma. Amyloid fibrils were largely
immobilized in the streptavidin-coated area. (b) Typical SEM image
of an area that was oxygen plasma treated with not many immobilized
peptide fibrils. (c) Typical SEM image of a streptavidin-coated
(untreated) area with many immobilized peptide fibrils. (d)
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IAPP21−27), we applied experimental alanine scanning
combined with computational methods. We identified phenyl-
alanine (F23), leucine (L27), and isoleucine (I26) as key
residues emphasizing the role of aromatic/hydrophobic
interactions for fibrillation, which is in agreement with previous
studies of the non-biotinylated peptide. Asparagine (N21) and
glycine (G24) played a minor role for fibril formation and are
thus potential targets for further peptide modifications. We
have demonstrated the spatially controlled immobilization of
such fibrils on surfaces as a proof-of-concept for their
integration into microfluidic systems.
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August-Universitaẗ Göttingen, Göttingen, Germany
Andrea Prager − Leibniz-Institute of Surface Engineering
(IOM), Leipzig, Germany
Christian Elsner − Leibniz-Institute of Surface
Engineering (IOM), Leipzig, Germany
Complete contact information is available at:
https://pubs.acs.org/10.1021/acs.biomac.9b01466
Author Contributions
The study was designed by C.E., T.J., and B.A. ThT
experiments were performed and analyzed by N.S., J.B., and
C.E. SEM measurements were performed by A.P. Surface
immobilization was done by C.E. and N.S. Peptides were
synthesized by J.B. and C.E. Computer simulations and
theoretical predictions were planned, performed, and analyzed
by T.J. Mass spectrometry was performed by J.B. and C.H. The
experimental and theoretical results were interpreted by C.E.,
T.J., N.S., H.J.R., and B.A. The manuscript was written by C.E.
and T.J. All authors have given approval to the final version of
the manuscript.
Funding
This research was financially supported by the Deutsche
Forschungsgemeinschaft (DFG, German Research Founda-
tion, Project 189853844, SFB-TRR 102, B1). T.J. thanks the
Friedrich-Ebert-Stiftung for a PhD fellowship.
Notes
The authors declare no competing financial interest.
■ REFERENCES
(1) Ke, P. C.; Sani, M. A.; Ding, F.; Kakinen, A.; Javed, I.; Separovic,
F.; Davis, T. P.; Mezzenga, R. Implications of Peptide Assemblies in
Amyloid Diseases. Chem. Soc. Rev. 2017, 46 (21), 6492−6531.
(2) Chiti, F.; Dobson, C. M. Protein Misfolding, Amyloid
Formation, and Human Disease: A Summary of Progress Over the
Last Decade. Annu. Rev. Biochem. 2017, 86 (1), 27−68.
(3) Wei, G.; Su, Z.; Reynolds, N. P.; Arosio, P.; Hamley, I. W.; Gazit,
E.; Mezzenga, R. Self-Assembling Peptide and Protein Amyloids:
From Structure to Tailored Function in Nanotechnology. Chem. Soc.
Rev. 2017, 46 (15), 4661−4708.
(4) Hauser, C. A. E.; Maurer-Stroh, S.; Martins, I. C. Amyloid-Based
Nanosensors and Nanodevices. Chem. Soc. Rev. 2014, 43 (15), 5326−
5345.
(5) Feng, Y.; Wang, H.; Zhang, J.; Song, Y.; Meng, M.; Mi, J.; Yin,
H.; Liu, L. Bio-Inspired Synthesis of Au Nanostructures Templated
from Amyloid β Peptide Assembly with Enhanced Catalytic Activity.
Biomacromolecules 2018, 19, 2432−2442.
(6) Bandak, J.; Petzold, J.; Hatahet, H.; Prager, A.; Kersting, B.;
Elsner, C.; Abel, B. Interconnected Electrocatalytic Pt-Metal Net-
works by Plasma Treatment of Nanoparticle-Peptide Fibril
Assemblies. RSC Adv. 2019, 9 (10), 5558−5569.
(7) Elsner, C.; Hintzen, D.; Prager, A.; Siefermann, K. R.; Abel, B.
Supramolecular Assembly of Functional Hybrid Fibrils with Peptide-
π-System-Peptide Monomers Near Silver-Nanoparticles. Z. Phys.
Chem. 2015, 229 (3), 427−442.
(8) Garvey, M.; Gras, S. L.; Meehan, S.; Meade, S. J.; Carver, J. A.;
Gerrard, J. A. Protein Nanofibres of Defined Morphology Prepared
from Mixtures of Crude Crystallins. Int. J. Nanotechnol. 2009, 6 (3−
4), 258−273.
(9) Li, D.; Jones, E. M.; Sawaya, M. R.; Furukawa, H.; Luo, F.;
Ivanova, M.; Sievers, S. A.; Wang, W.; Yaghi, O. M.; Liu, C.;
Eisenberg, D. S. Structure-Based Design of Functional Amyloid
Materials. J. Am. Chem. Soc. 2014, 136 (52), 18044−18051.
(10) Norlin, N.; Hellberg, M.; Filippov, A.; Sousa, A. A.; Gröbner,
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